Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

iChip01:24

iChip

The cultivation of environmental microorganisms has long been hindered by the inability to replicate complex native conditions in vitro. The isolation chip (iChip) addresses this limitation by facilitating the growth of previously uncultivable microorganisms through in situ incubation. Designed for high-throughput microbial cultivation, the iChip comprises hundreds of microchambers, each capable of housing a single microbial cell. These microchambers are loaded with a mixture of molten agar and...
Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Bioreactor Design and Operational System01:29

Bioreactor Design and Operational System

Bioreactors are engineered vessels designed to cultivate microorganisms under controlled conditions for industrial bioprocessing. They maintain sterility and allow precise regulation of pH, temperature, oxygen, and nutrient levels to optimize microbial growth and metabolite production. Bioreactors range from small laboratory units of 1 liter to industrial systems holding up to 500,000 liters, though only about 75% of their volume is actively used for fermentation. The remaining headspace...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chitosan-Loaded Melatonin Carbon Dots-Copper Nanocomposite Improves Rice Seedling Salt Tolerance via Scavenging-Regulation-Repair Trilevel Synergistic Mechanisms.

Journal of agricultural and food chemistry·2026
Same author

Emerging Roles of Nanozymes in Plant and Environmental Sectors.

Journal of agricultural and food chemistry·2024
Same author

Chitosan-Se Engineered Nanomaterial Mitigates Salt Stress in Plants by Scavenging Reactive Oxygen Species.

Journal of agricultural and food chemistry·2023
Same author

Engineering a Red Fluorescent Protein Chromophore for Visualization of RNA G-Quadruplexes.

Biochemistry·2023
Same author

Nanozyme-based dual-signal sensing system for colorimetric and photothermal detection of AChE activity in the blood of liver-injured mice.

Analytical and bioanalytical chemistry·2023
Same author

FeOOH nanosheet assisted metal ion coordination with porphyrins for rapid detection and removal of cadmium ions in water.

Analytical methods : advancing methods and applications·2022

Related Experiment Video

Updated: Jul 14, 2026

Bioreactor Assembly for Continuous Culture of Complex Fecal Communities
09:37

Bioreactor Assembly for Continuous Culture of Complex Fecal Communities

Published on: April 25, 2025

Bioinspired microcapsule reactor with engineered probiotics for IBD therapy.

Minhui Xu1, Yuanchun Du2, Guangfu Feng3

  • 1College of Bioscience and Biotechnology, Hunan Agricultural University, Changsha, Hunan, China.

Nature Communications
|July 12, 2026
PubMed
Summary

Engineered bacteria in bionic microcapsules effectively treat inflammatory bowel disease by sensing inflammation and releasing therapeutic peptides, improving gut health and reducing systemic inflammation.

More Related Videos

A Novel Method for the Culture and Polarized Stimulation of Human Intestinal Mucosa Explants
06:38

A Novel Method for the Culture and Polarized Stimulation of Human Intestinal Mucosa Explants

Published on: May 1, 2013

Updated Protocol for the Assembly and Use of the Minibioreactor Array (MBRA)
09:38

Updated Protocol for the Assembly and Use of the Minibioreactor Array (MBRA)

Published on: September 5, 2025

Related Experiment Videos

Last Updated: Jul 14, 2026

Bioreactor Assembly for Continuous Culture of Complex Fecal Communities
09:37

Bioreactor Assembly for Continuous Culture of Complex Fecal Communities

Published on: April 25, 2025

A Novel Method for the Culture and Polarized Stimulation of Human Intestinal Mucosa Explants
06:38

A Novel Method for the Culture and Polarized Stimulation of Human Intestinal Mucosa Explants

Published on: May 1, 2013

Updated Protocol for the Assembly and Use of the Minibioreactor Array (MBRA)
09:38

Updated Protocol for the Assembly and Use of the Minibioreactor Array (MBRA)

Published on: September 5, 2025

Area of Science:

  • Biomedical Engineering
  • Microbiology
  • Immunology

Background:

  • Probiotic bionic strategies for inflammatory bowel disease (IBD) face challenges like poor survival and targeting.
  • Coral reef defense mechanisms inspire a novel bionic approach.

Purpose of the Study:

  • To develop a core-shell bionic microcapsule reactor (MY-E@SS) for effective IBD therapy.
  • To create an intelligent platform for modulating inflammatory microenvironments.

Main Methods:

  • Developed MY-E@SS encapsulating engineered bacteria.
  • Tested delivery and therapeutic efficacy in a male murine model of IBD.
  • Investigated mechanisms including TNF-α/NF-κB signaling pathway inhibition.

Main Results:

  • MY-E@SS ensured safe delivery and colonization of engineered bacteria.
  • The system responsively released anti-inflammatory peptides at inflamed sites.
  • Demonstrated significant therapeutic efficacy: restored gut barrier, reduced inflammation and oxidative stress, modulated metabolism, and reestablished microbial balance.

Conclusions:

  • The bionic microcapsule platform offers a promising strategy for IBD treatment.
  • This intelligent system effectively modulates inflammatory microenvironments for complex diseases.